These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8720472)

  • 1. Modulation of opioid analgesia by agmatine.
    Kolesnikov Y; Jain S; Pasternak GW
    Eur J Pharmacol; 1996 Jan; 296(1):17-22. PubMed ID: 8720472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraspinally administered agmatine prevents the development of supraspinal morphine analgesic tolerance.
    Kitto KF; Fairbanks CA
    Eur J Pharmacol; 2006 Apr; 536(1-2):133-7. PubMed ID: 16546161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY; Tseng LF
    Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance.
    Kolesnikov YA; Maccechini ML; Pasternak GW
    Life Sci; 1994; 55(18):1393-8. PubMed ID: 7934650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.
    King MA; Bradshaw S; Chang AH; Pintar JE; Pasternak GW
    J Neurosci; 2001 Oct; 21(19):7788-92. PubMed ID: 11567069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse.
    Suh HW; Song DK; Lee KJ; Choi SR; Kim YH
    Neuropeptides; 1996 Aug; 30(4):373-8. PubMed ID: 8914864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
    Stevens CW; Rothe KS
    Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonism of opioid analgesia by a sigma system.
    Chien CC; Pasternak GW
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect.
    Kolesnikov Y; Jain S; Wilson R; Pasternak GW
    J Pharmacol Exp Ther; 1998 Feb; 284(2):455-9. PubMed ID: 9454784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D; Pick CG; Tive LA; Pasternak GW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.